| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.31B | — | +17.6% |
| Cost of Revenue | $697.0M | — | +18.7% |
| R&D Expense | $94.0M | — | +11.9% |
| SG&A Expense | $173.0M | — | +23.6% |
| Interest Expense | $61.0M | — | — |
| Pre-tax Income | $218.0M | — | -11.4% |
| Income Tax | $56.0M | — | +19.1% |
| Net Income | $162.0M | — | -18.6% |
| EPS (Basic) | $0.72 | — | -21.7% |
| EPS (Diluted) | $0.72 | — | -21.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $857.0M | -6.3% | — |
| Accounts Receivable | $1.04B | +58.4% | — |
| Inventory | $696.0M | +5.3% | — |
| Current Assets | $2.68B | +1.7% | — |
| Total Assets | $14.06B | -0.0% | — |
| Current Liabilities | $1.26B | -6.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $135.0M | — | -34.8% |
| Investing Cash Flow | -$123.0M | — | -18.3% |
| Financing Cash Flow | -$59.0M | — | +45.9% |
| Long-term Debt | $4.00B | -2.4% | — |
| Total Liabilities | $6.60B | -1.5% | — |
| Stockholders' Equity | $7.19B | +1.3% | -34.9% |